Translational Research Office
Boundary Brook House
Head of Translational Research Office
As Head of the Translational Research Office (TRO), I am responsible for “driving exciting research discoveries along the translational research pathway resulting in the development of new therapeutics, devices and clinical techniques”.
My role involves:
- Building excellent knowledge of external resources for translational project funding available to researchers and their respective selection criteria.
- Supporting the strategic allocation of internal funding streams for translational research
- Providing advice around translational pathway planning
- Supporting translational funding applications
- Providing an extensive, centralised network of external (industry) and internal (academic, clinical, Business Development, OUI and Research Services) stakeholders
- Translational project management (milestones, direct bid writing support)
- Supporting successful follow-on funding strategies and applications
Before joining the TRO I was a research manager for the Wade-Martins’ Lab in the Department of Physiology and Genetics for just over a two years. My role here involved the management of the stem cell culture facilities (specialising in human patient derived iPSCs) as well as providing expertise in using state-of-the-art equipment which included the ECHO nanodrop dispenser, the Opera Phenix and the PHERAstar FSX HTS microplate reader. These facilities were funded by the Dementia Platform UK (DPUK) Stem Cell Network and the Oxford Parkinson’s Disease Centre. New collaborations were established with other research groups, academic or industrial based in order to exploit the platform technologies.
Prior to this, I completed my PhD at Keele University investigating the synergistic effects of synthetic electrospun scaffolds and oxygen tension on the expansion of pluripotent human embryonic stem cells. My postdoctoral research experience (Loughborough University and University of Manchester) has largely been at the interface of biomaterials (electrospun devices and hydrogels), tissue engineering, regenerative medicine, bioreactors, stem cells and tissue-specific primary cells. I also have experience in the development of in vitro 3D tissue engineering models, which aim to closely mimic the in vivo extracellular matrix environment, with examples including: bone, anterior cruciate ligament, oesophageal tissue, neural tissue and aortic valves.